Related Experiment Videos
Partial purification of [3H]mianserin binding sites
European Journal of Pharmacology
|March 4, 1983
Summary
This study shows that [3H]mianserin binding in the frontal cortex exhibits both histamine and serotonin properties. These binding components could not be separated using common biochemical techniques.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Mianserin is a drug known to interact with both histamine and serotonin receptors.
- Understanding the specific binding characteristics of mianserin in the frontal cortex is crucial for its therapeutic applications.
Purpose of the Study:
- To investigate the binding properties of [3H]mianserin in human frontal cortex membranes.
- To determine if histaminergic and serotonergic binding components of [3H]mianserin can be separated.
Main Methods:
- Solubilization of frontal cortex membranes using digitonin.
- Pre-labeling with [3H]mianserin and partial purification via isoelectric focusing.
- Pharmacological characterization using ketanserin, chlorpyramine, and spiperone.
Main Results:
- A single radioactive peak with a pI of 5.03 was observed after isoelectric focusing, indicating a 14-fold purification.
- The presence of ketanserin, chlorpyramine, or spiperone abolished the radioactivity peak.
- Pharmacological analysis of the eluted peak confirmed both histaminergic and serotonergic binding properties.
Conclusions:
- The histaminergic and serotonergic binding components of [3H]mianserin in the frontal cortex are not separable by standard biochemical methods like solubilization, gel filtration, or isoelectric focusing.
- This suggests a co-localization or complex interaction of these binding sites.